Terms ending in 2030
Every in-force patent on Sanofi's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,084,730 | Pharmaceutical Composition Comprising a Solid Dispersion with a Polymer Matrix Containing a Continuous Polydextrose Phase and a Continuous Phase of a Polymer Other Than Polydextrose In force · High confidence | Sanofi | In force | High confidence | |
| US 8,633,301 | Antitumor Combinations Containing Antibodies Recognizing Specifically CD38 and Vincristine In force · High confidence | Sanofi | In force | High confidence | |
| US 8,703,095 | Immuno-adjuvant emulsion In force · High confidence | Sanofi Pasteur S.A. | In force | High confidence | |
| US 9,504,659 | Thermoreversible Oil-In-Water Emulsion In force · High confidence | Sanofi Pasteur S.A. | In force | High confidence | |
| US RE47,123 | EPHA2 Receptor Antagonist Antibodies In force · Low confidence | Sanofi | In force | Low confidence | |
| US 8,574,865 | Methods and Assays for Identifying Compounds That Modulate Protein-Protein Interactions In force · High confidence | Sanofi | In force | High confidence | |
| US 8,394,787 | 7-AZA-SPIRO[3.5]NONANE-7-Carboxylate Derivatives, Preparation Thereof and Therapeutic Use Thereof In force · High confidence | Sanofi | In force | High confidence | |
| US 9,750,800 | Method for Purifying the Rabies Virus In force · High confidence | Sanofi Pasteur S.A. | In force | High confidence | |
| US RE47,768 | Compositions and Methods for the Production of Alpha-Herpesviruses In force · Low confidence | Sanofi Pasteur Biologics LLC | In force | Low confidence | |
| US 8,551,527 | Process for Stabilizing an Adjuvant Containing Vaccine Composition In force · High confidence | Sanofi Pasteur S.A. | In force | High confidence | |
| 34 more term ends in 2030 · Pro | |||||
10 of 44 patents shown. Soonest term end first, then patent number.
Pro members see all 44.
43 of these are in force and held by Sanofi.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.